The Thing That Gets People Into Treatment Was Never the Syringe. It Was the Person Handing It Over.
Cutting harm reduction supplies doesn't just remove equipment. It removes the one relationship in a lot of people's week that isn't trying to fix them — and that relationship is the actual mechanism behind the treatment-entry numbers.
You don’t walk into a treatment intake appointment because a stranger told you to. Almost nobody does. Most people who get into treatment for opioid use get there because someone they already trusted — a friend, a doctor, sometimes a syringe program worker who showed up at the same spot every week for a year without once telling them to stop — made it feel like a door instead of a wall. That’s not a sentiment. It’s a documented pattern with a number attached: people who use syringe service programs are roughly five times more likely to enter drug treatment than people who don’t, and about three times as likely to cut back or stop injecting.
The equipment was never the mechanism. The relationship was — and relationships don’t survive a program losing its funding, even when the building technically stays open.
Psychologists who work in this specific field have a name for what’s actually happening in that five-times number: therapeutic alliance — the working trust between a person and whoever is trying to help them, built through respect instead of pressure. Andrew Tatarsky, the psychologist who developed Integrative Harm Reduction Psychotherapy, has spent decades making the same clinical argument: the alliance forms when people feel “empathically recognized and offered help that meets their needs as they experience them” — not help that requires them to already be somewhere they’re not yet ready to be. Psychotherapy Networker’s reporting on the model puts the mechanism even more plainly: when people feel respected instead of coerced, engagement goes up and outcomes get better. Nobody builds that kind of trust with an agency. They build it with a specific person, on a specific corner, showing up on a specific day, week after week, without an ultimatum attached.
That’s the part the funding math misses entirely. A grant spreadsheet sees a line item for “syringes distributed” or “test strips purchased” and a line item for “outreach staff hours,” and treats them as separable — cut the supplies, keep the relationship, no problem. It doesn’t work that way on the ground. The supplies are the reason the relationship exists in the first place; they’re the thing that gets a worker invited back to the same corner next Tuesday. Take away what the worker has to offer and you don’t get the same relationship for less money — you get fewer reasons for anyone to show up, on either side of the exchange.
If you’re the person on the receiving end of one of these programs, here is the part worth holding onto: the trust you’ve built with someone who’s shown up for you was never contingent on the specific item in their hand. If your program loses its test-strip funding, that person — if they’re still able to show up at all — is still the same person, still not there to arrest you, still the closest thing to a door you may currently have. Funding cuts can take away what an outreach worker is allowed to carry. They can’t retroactively make the relationship any less real, and they can’t stop you from asking that same person, today, what still exists that can help.
Sources Cited
- 01.A
- 02.BThe Challenge of Harm ReductionPsychotherapy Networker
- 03.BIntegrative Harm Reduction PsychotherapyAndrew Tatarsky, PhD
Filed Under
psychologyharm-reductiontreatmentHarm ReductionPsychology
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
There's Still No Pill for Cocaine. The Treatment That Works Pays You Instead — and Most States Won't Cover It.
There is no FDA-approved medication for cocaine or meth addiction. The one treatment with the strongest evidence base pays people for negative drug tests — and only five state Medicaid programs cover it.
Treatment & RecoveryRural ERs Still Aren't Starting Addiction Medication. Six Years of Data Just Proved It.
A CDC report published August 27 shows rural emergency departments started buprenorphine in overdose patients at a third the rate of urban EDs, a gap that hasn't moved since 2019 — a fixable protocol problem hiding inside a national success story.
Treatment & RecoveryWashington Built the Playbook That Cut Overdose Deaths. It Just Told States to Stop Using It.
HHS just told cities to drop harm reduction for a 'Treatment First' model. The fentanyl test strips and syringe programs it's defunding are the same tools credited with the overdose decline it's celebrating.